POLSINELLI PC for TEVA PHARMACEUTICALS USA, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.1865, FY2020 Further Consolidated Appropriations Act Administration review of drug pricing policies
Foreign entity interest: Teva Pharmaceutical Industries LTD, as the indirect parent of TEVA Pharmaceuticals USA INC, has an interest in the issues listed.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES DAVIDSON | — |
| JULIUS W HOBSON | — |
| SYLVIA STANOJEV KORNEGAY | — |
| HARRY ANASTASIOS SPORIDIS | — |
| STEVEN STRANNE | — |
Pharmacy PHA
S.2543, Prescription Drug Pricing Reduction Act S.1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act H.R.1865, FY2020 Further Consolidated Appropriations Act Administration review of drug pricing policies
Foreign entity interest: Teva Pharmaceutical Industries LTD, as the indirect parent of TEVA Pharmaceuticals USA INC, has an interest in the issues listed.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES DAVIDSON | — |
| JULIUS W HOBSON | — |
| SYLVIA STANOJEV KORNEGAY | — |
| HARRY ANASTASIOS SPORIDIS | — |
| STEVEN STRANNE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.